{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:27:57Z","timestamp":1790116077648,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T00:00:00Z","timestamp":1450828800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00702-015-1496-z","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T09:21:54Z","timestamp":1450862514000},"page":"407-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The effect of levodopa\u2013carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson\u2019s disease: a multicenter Romanian experience"],"prefix":"10.1007","volume":"123","author":[{"given":"O.","family":"B\u0103jenaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. O.","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Sz\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sab\u0103u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. F.","family":"Mure\u015fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Perju-Dumbrava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. D.","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Buraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9676-1282","authenticated-orcid":false,"given":"M.","family":"Simu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,23]]},"reference":[{"issue":"3","key":"1496_CR1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","volume":"16","author":"JE Ahlskog","year":"2001","unstructured":"Ahlskog JE, Muenter MD (2001) Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16(3):448\u2013458","journal-title":"Mov Disord"},{"key":"1496_CR2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1212\/WNL.0b013e318285c16d","volume":"80","author":"A Antonini","year":"2013","unstructured":"Antonini A, Albin RL (2013) Dopaminergic treatment and nonmotor features of Parkinson disease: the horse lives. Neurology 80:784\u2013785","journal-title":"Neurology"},{"issue":"6","key":"1496_CR3","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1586\/ern.09.48","volume":"9","author":"A Antonini","year":"2009","unstructured":"Antonini A, Tolosa E (2009) Apomorphine and levodopa infusion therapies for advanced Parkinson\u2019s disease: selection criteria and patient management. Expert Rev Neurother 9(6):859\u2013867","journal-title":"Expert Rev Neurother"},{"key":"1496_CR4","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00702-013-1026-9","volume":"120","author":"A Antonini","year":"2013","unstructured":"Antonini A, Odin P, Opiano L, Tomantschger V, Pacchetti C, Pickut B, Gasser UE, Calandrella D, Mancini F, Zibetti M, Minafra B, Bertaina I, De Deyn P, Cras C, Wolf E, Spielberger S, Poewe W (2013) Effect and safety of duodenal levodopa infusion in advanced Parkinson\u2019s disease: a retrospective multicenter outcome assessment in patient routine care. J Neural Transm 120:1553\u20131558","journal-title":"J Neural Transm"},{"key":"1496_CR5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.parkreldis.2014.12.012","volume":"21","author":"A Antonini","year":"2015","unstructured":"Antonini A, Yegin A, Preda C, Bergmann L, Poewe W, GLORIA study investigators and coordinators (2015) Global long-term study on motor and non-motor symptoms and safety of levodopa\u2013carbidopa intestinal gel in routine care of advanced Parkinson\u2019s disease patients; 12-month interim outcomes. Parkinsonism Relat Disord 21:231\u2013235","journal-title":"Parkinsonism Relat Disord"},{"key":"1496_CR6","first-page":"251","volume":"156","author":"GL Defer","year":"2000","unstructured":"Defer GL (2000) Surgical treatment: inclusion criteria. Rev Neurol (Paris) 156:251\u2013256","journal-title":"Rev Neurol (Paris)"},{"key":"1496_CR7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/mds.22450","volume":"24","author":"D Devos","year":"2009","unstructured":"Devos D (2009) Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson\u2019s disease. Mov Disord 24:993\u20131000","journal-title":"Mov Disord"},{"key":"1496_CR8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0035-3787(06)75115-3","volume":"162","author":"S Drapier","year":"2006","unstructured":"Drapier S, V\u00e9rin M (2006) Continuous subcutaneous infusion of apomorphine for the treatment of Parkinson\u2019s disease. Rev Neurol (Paris) 162:1019\u20131023","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"1496_CR9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.parkreldis.2012.11.020","volume":"19","author":"HH Fernandez","year":"2013","unstructured":"Fernandez HH, Vanagunas A, Odin P et al (2013) Levodopa\u2013carbidopa intestinal gel in advanced Parkinson\u2019s disease open-label study: interim results. Parkinsonism Relat Disord 19(3):339\u2013345","journal-title":"Parkinsonism Relat Disord"},{"key":"1496_CR10","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/mds.22596","volume":"24","author":"H Honig","year":"2009","unstructured":"Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye CG, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR (2009) Intrajejunal levodopa infusion in Parkinson\u2019s disease: a pilot multicenter study of effects on non-motor symptoms and quality of life. Mov Disord 24:1468\u20131474","journal-title":"Mov Disord"},{"key":"1496_CR11","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa035275","volume":"394","author":"P Krach","year":"2003","unstructured":"Krach P, Batir A, von Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease. N Engl J Med 394:1925\u20131934","journal-title":"N Engl J Med"},{"key":"1496_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2013.09.007","volume":"20","author":"F Mancini","year":"2014","unstructured":"Mancini F, Comi C, Oggioni GD, Pacchetti C, Calandrella D, Coletti Moja M, Riboldazzi G, Tunesi S, Dal Fante M, Manfredi L, Lacerenza M, Cantello R, Antonini A (2014) Prevalence and features of peripheral neuropathy in Parkinson\u2019s disease patients under different therapeutic regimens. Parkinsonism Relat Disord 20:27\u201331","journal-title":"Parkinsonism Relat Disord"},{"key":"1496_CR13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.parkreldis.2006.12.013","volume":"13","author":"L Morgante","year":"2007","unstructured":"Morgante L, Morgante F, Moro E, Epifanio A, Girlanda P, Ragonese P, Antonini A, Barone P, Bonuccelli U, Contarino MF, Capus L, Ceravolo MG, Marconi R, Ceravolo R, D\u2019Amelio M, Savettieri G (2007) How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism Relat Disord 13:528\u2013531","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"1496_CR14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.parkreldis.2012.06.022","volume":"18","author":"D Nyholm","year":"2012","unstructured":"Nyholm D (2012) Duodopa\u00ae treatment for advanced Parkinson\u2019s disease: a review of efficacy and safety. Parkinsonism Relat Disord 18(8):916\u2013929","journal-title":"Parkinsonism Relat Disord"},{"key":"1496_CR15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00002826-200305000-00010","volume":"26","author":"D Nyholm","year":"2003","unstructured":"Nyholm D, Askmark H, Gomes-Trolin C, Knutson T, Lennern\u00e4s H, Nystr\u00f6m C, Aquilonius SM (2003) Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets. Clin Neuropharmacol 26:156\u2013163","journal-title":"Clin Neuropharmacol"},{"key":"1496_CR16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1212\/01.WNL.0000149637.70961.4C","volume":"64","author":"D Nyholm","year":"2005","unstructured":"Nyholm D, Nilsson Remahl AIM, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H (2005) Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 64:216\u2013223","journal-title":"Neurology"},{"key":"1496_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/WNF.0b013e3180ed449f","volume":"31","author":"D Nyholm","year":"2008","unstructured":"Nyholm D, Lewander T, Johansson A, Lewitt PA, Lundqvist C, Aquilonius SM (2008) Enteral levodopa\/carbidopa infusion in advanced Parkinson disease: long-term exposure. Clin Neuropharmacol 31:63\u201373","journal-title":"Clin Neuropharmacol"},{"key":"1496_CR18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1468-1331.2012.03679.x","volume":"19","author":"D Nyholm","year":"2012","unstructured":"Nyholm D, Klangemo K, Johansson A (2012) Levodopa\/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson\u2019s disease. Eur J Neurol 19:1079\u20131085","journal-title":"Eur J Neurol"},{"issue":"11 Suppl 5","key":"1496_CR19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.56.suppl_5.S1","volume":"56","author":"CW Olanow","year":"2001","unstructured":"Olanow CW, Watts RL, Koller WC (2001) An algorithm (decision tree) for the management of Parkinson\u2019s disease (2001): treatment guidelines. Neurology 56(11 Suppl 5):S1","journal-title":"Neurology"},{"key":"1496_CR20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","volume":"13","author":"CW Olanow","year":"2014","unstructured":"Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A, LCIG Horizon Study Group (2014) Continuous intrajejunal infusion of levodopa\u2013carbidopa intestinal gel for patients with advanced Parkinson\u2019s disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol 13:141\u2013149","journal-title":"Lancet Neurol"},{"key":"1496_CR21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/1531-8257(200009)15:5<789::AID-MDS1005>3.0.CO;2-H","volume":"5","author":"W Poewe","year":"2000","unstructured":"Poewe W, Wenning GK (2000) Apomorphine: an underutilized therapy for Parkinson\u2019s disease. Mov Disord 5:789\u2013794","journal-title":"Mov Disord"},{"key":"1496_CR22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/mds.23714","volume":"26","author":"O Rascol","year":"2011","unstructured":"Rascol O, Lozano A, Stern M, Poewe W (2011) Milestones in Parkinson\u2019s disease therapeutics. Mov Disord 26:1072\u20131082","journal-title":"Mov Disord"},{"key":"1496_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1227\/01.NEU.0000285347.50028.B9","volume":"61","author":"M Tir","year":"2007","unstructured":"Tir M, Devos D, Blond S, Touzet G, Reyns N, Duhamel A, Cottencin O, Dujardin K, Cassim F, Dest\u00e9e A, Defebvre L, Krystkowiak P (2007) Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single center cohort of parkinsonian patients. Neurosurgery 61:297\u2013304","journal-title":"Neurosurgery"},{"key":"1496_CR24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.parkreldis.2013.08.012","volume":"19","author":"A Todorova","year":"2013","unstructured":"Todorova A, Ray Chaudhuri K (2013) Subcutaneous apomorphine and non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 19:1073\u20131078","journal-title":"Parkinsonism Relat Disord"},{"key":"1496_CR25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/practneurol-2013-000741","volume":"14","author":"A Todorova","year":"2014","unstructured":"Todorova A, Jenner P, Chaudhuri KR (2014) Non-motor Parkinson\u2019s: integral to motor Parkinson\u2019s, yet often neglected. Pract Neurol 14:310\u2013322","journal-title":"Pract Neurol"},{"key":"1496_CR26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/ene.12309","volume":"21","author":"M Zibetti","year":"2013","unstructured":"Zibetti M, Merola A, Artusi CA, Rizzi L, Angrisano S, Reggio D, De Angelis C, Rizzone M, Lopiano L (2013a) Levodopa\/carbidopa intestinal gel infusion in advanced Parkinson\u2019s disease: a 7-year experience. Eur J Neurol 21:312\u2013318","journal-title":"Eur J Neurol"},{"issue":"1","key":"1496_CR27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00415-012-6597-0","volume":"260","author":"M Zibetti","year":"2013","unstructured":"Zibetti M, Merola A, Ricchi V et al (2013b) Long-term duodenal levodopa infusion in Parkinson\u2019s disease: a 3-year motor and cognitive follow-up study. J Neurol 260(1):105\u2013114","journal-title":"J Neurol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-015-1496-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-015-1496-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-015-1496-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:07:23Z","timestamp":1553612843000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-015-1496-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,23]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1007\/s00702-015-1496-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,23]]}}}